Reduced transmission of Mycobacterium africanum compared to Mycobacterium tuberculosis in urban West Africa

被引:27
|
作者
Asare, Prince [1 ,2 ,3 ]
Asante-Poku, Adwoa [1 ]
Prah, Diana Ahu [1 ]
Borrell, Sonia [4 ,5 ]
Osei-Wusu, Stephen [1 ]
Otchere, Isaac Darko [1 ]
Forson, Audrey [6 ]
Adjapong, Gloria [7 ]
Koram, Kwadwo Ansah [1 ]
Gagneux, Sebastien [4 ,5 ]
Yeboah-Manu, Dorothy [1 ]
机构
[1] Univ Ghana, NMIMR, Legon, Ghana
[2] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana
[3] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Ghana
[4] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[5] Univ Basel, Basel, Switzerland
[6] Korle Bu Teaching Hosp, Korle Bu, Accra, Ghana
[7] Ctr Plant Med Res, Mampong, Ghana
基金
英国惠康基金;
关键词
Mycobacterium tuberculosis; Mycobacterium africanum; Transmission; Molecular epidemiology; MIRU-VNTR; Spoligotyping; MULTIDRUG-RESISTANT TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; TB TRANSMISSION; COMPLEX; STRAINS; LINEAGE; LONDON; UK;
D O I
10.1016/j.ijid.2018.05.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Understanding transmission dynamics is useful for tuberculosis (TB) control. A population-based molecular epidemiological study was conducted to determine TB transmission in Ghana. Methods: Mycobacterium tuberculosis complex (MTBC) isolates obtained from prospectively sampled pulmonary TB patients between July 2012 and December 2015 were characterized using spoligotyping and standard 15-locus mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing for transmission studies. Results: Out of 2309 MTBC isolates, 1082 (46.9%) unique cases were identified, with 1227 (53.1%) isolates belonging to one of 276 clusters. The recent TB transmission rate was estimated to be 41.2%. Whereas TB strains of lineage 4 belonging to M. tuberculosis showed a high recent transmission rate (44.9%), reduced recent transmission rates were found for lineages of Mycobacterium africanum (lineage 5, 31.8%; lineage 6, 24.7%). Conclusions: The study findings indicate high recent TB transmission, suggesting the occurrence of unsuspected outbreaks in Ghana. The observed reduced transmission rate of M. africanum suggests other factor(s) (host/environmental) may be responsible for its continuous presence in West Africa. (C) 2018 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:30 / 42
页数:13
相关论文
共 50 条
  • [21] BONE TUBERCULOSIS DUE TO MYCOBACTERIUM-AFRICANUM - 2 CASES
    PETIT, JC
    LESAGE, D
    DAGUET, GL
    NOUVELLE PRESSE MEDICALE, 1980, 9 (38): : 2845 - 2845
  • [22] Disseminated tuberculosis in hyrax (Procavia capensis) caused by Mycobacterium africanum
    Gudan, Andrea
    Artukovic, Branka
    Cvetnic, Zeljko
    Spicic, Silvio
    Beck, Ana
    Hohsteter, Marko
    Naglic, Tomo
    Bata, Ingehorg
    Grabarevic, Zeljko
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2008, 39 (03) : 386 - 391
  • [23] Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M-bovis BCG
    Rastogi, N
    Goh, KS
    Berchel, M
    Bryskier, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) : 565 - 570
  • [24] Laboratory transmission of Mycobacterium tuberculosis
    Bemer-Melchior, P
    Gouzer'h, MJ
    Drugeon, HB
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (08): : 610 - 610
  • [25] Newly Identified Mycobacterium africanum Lineage 10, Central Africa
    Guyeux, Christophe
    Senelle, Gaetan
    Le Meur, Adrien
    Supply, Philip
    Gaudin, Cyril
    Phelan, Jody E.
    Clark, Taane G.
    Rigouts, Leen
    de Jong, Bouke
    Sola, Christophe
    Refregier, Guislaine
    EMERGING INFECTIOUS DISEASES, 2024, 30 (03) : 560 - 563
  • [26] Immunogenic Mycobacterium africanum Strains Associated with Ongoing Transmission in The Gambia
    Gehre, Florian
    Antonio, Martin
    Otu, Jacob K.
    Sallah, Neneh
    Secka, Oumie
    Faal, Tutty
    Owiafe, Patrick
    Sutherland, Jayne S.
    Adetifa, Ifedayo M.
    Ota, Martin O.
    Kampmann, Beate
    Corrah, Tumani
    de Jong, Bouke C.
    EMERGING INFECTIOUS DISEASES, 2013, 19 (10) : 1598 - 1604
  • [27] INVITRO ACTIVITY OF CIPROFLOXACIN AND OFLOXACIN AGAINST MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-AFRICANUM, MYCOBACTERIUM-KANSASII, AND STRAINS OF BCG
    THOMAS, L
    NAUMANN, P
    CREA, A
    IMMUNITAT UND INFEKTION, 1986, 14 (06): : 203 - 207
  • [28] Differences in T- cell responses between Mycobacterium tuberculosis and Mycobacterium africanum- infected patients
    Tientcheu, Leopold D.
    Sutherland, Jayne S.
    de Jong, Bouke C.
    Kampmann, Beate
    Jafali, James
    Adetifa, Ifedayo M.
    Antonio, Martin
    Dockrell, Hazel M.
    Ota, Martin O.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (05) : 1387 - 1398
  • [29] ULCERATIVE TUBERCULOSIS OF THE ANAL-CANAL DUE TO MYCOBACTERIUM-AFRICANUM
    JANIER, M
    WAGNER, L
    CHEMALY, P
    BELLANGER, J
    DAVID, MC
    CASIN, I
    CONTOU, JF
    PEROL, Y
    CIVATTE, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1987, 114 (11): : 1395 - 1397
  • [30] INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AFRICANUM, MYCOBACTERIUM-BOVIS, MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-FORTUITUM, AND MYCOBACTERIUM-CHELONAE TO TICARCILLIN IN COMBINATION WITH CLAVULANIC ACID
    CASAL, MJ
    RODRIGUEZ, FC
    LUNA, MD
    BENAVENTE, MC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 132 - 133